Edwards Lifesciences Corporation company logo
Edwards Lifesciences Corporation logo

EW EBITDA

Annual EBITDA

$1.79B$187.40M+11.72%

Summary

Current Value
As of today, EW annual EBITDA is $1.79B, up +11.72% on
Historical Performance
EW annual EBITDA is down -4.40% over the past 3 years, up +24.84% over the past 5 years
All-Time High Comparison
EW annual EBITDA is currently -4.40% below its historical high of $1.87B set on
3-Year Low Comparison
EW annual EBITDA is +13.66% above its 3-year low of $1.57B reached on
Sector Comparison
EW annual EBITDA is higher than 95.38% of companies in Healthcare sector

EBITDA Chart

Add series to chart
Add series to chart1/6
Series
SUGGESTED SERIES

Performance

EW Performance
MetricDateValue1Y3Y5Y15Y
Annual EBITDA$1.79B+11.7%-4.4%+24.8%+427.1%
Quarterly EBITDA$420.20M+7.2%-6.9%+4.4%+350.9%
TTM EBITDA$1.79B+11.7%-4.3%+24.8%+427.1%
Price$86.47+20.7%+7.8%+0.2%+485.0%
PE Ratio47.87+366.1%+45.5%-28.0%-1.7%
Annual Revenue$6.07B+11.6%+12.7%+38.3%+319.3%
Annual EPS$1.81+24.0%-25.8%+38.9%+493.3%
$1.64B+13.3%-3.9%+26.3%+479.2%
Annual Net Income$1.06B-24.4%-30.6%+28.3%+384.4%

EBITDA Highs

EW Annual EBITDA Highs Comparison
PeriodHighDateCurrent
3Y$1.87BN/A-4.4%
5Y$1.87B-4.4%
All$1.87B-4.4%

EBITDA Lows

EW Annual EBITDA Lows Comparison
PeriodLowDateCurrent
3Y$1.57B+13.7%
5Y$1.43BN/A+24.8%
All$148.00M+1107.4%

EBITDA History

YearValueChange
$1.79B+11.7%
$1.60B+1.7%
$1.57B-15.9%
$1.87B+5.4%
$1.77B+23.9%
$1.43B+9.1%
$1.31B+12.2%
$1.17B+7.1%
$1.09B+23.2%
$886.70M+38.2%
$641.70M+15.5%
$555.80M+10.8%
$501.70M+10.5%
$454.00M+17.3%
$387.10M+14.2%
YearValueChange
$339.00M+16.2%
$291.70M+10.2%
$264.60M+18.0%
$224.30M+1.8%
$220.30M-5.0%
$231.80M+10.3%
$210.10M+14.2%
$184.00M+20.9%
$152.20M+2.8%
$148.00M-4.5%
$155.00M-2.5%
$159.00M-5.9%
$169.00M-14.6%
$198.00M-

FAQ

  • What is the current annual EBITDA of EW?

    As of today, EW annual EBITDA is $1.79B

  • What is 1-year change in EW annual EBITDA?

    EW annual EBITDA is up +11.72% year-over-year

  • What is 3-year change in EW annual EBITDA?

    EW annual EBITDA is down -4.40% over the past 3 years

  • How far is EW annual EBITDA from its all-time high?

    EW annual EBITDA is currently -4.40% below its historical high of $1.87B set on December 31, 2022

  • How does EW annual EBITDA rank versus sector peers?

    EW annual EBITDA is higher than 95.38% of companies in Healthcare sector

  • When is EW next annual earnings release?

    As of today, the next annual earnings release for EW has not been scheduled

EBITDA Formula

EBITDA = Net Income + + +

Data Sources & References

  1. EW Official Website www.edwards.com
  2. Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1099800/000109980026000009/0001099800-26-000009-index.htm
  3. Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1099800/000109980026000009/0001099800-26-000009-index.htm
  4. EW Profile on Yahoo Finance finance.yahoo.com/quote/EW
  5. EW Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/ew